$17.05 +0.97 (6.03%)
Aardvark Therapeutics, Inc. Common Stock (AARD)
Aardvark Therapeutics, Inc. (AARD) is a biotechnology company focused on developing innovative therapies for neurological and neurodegenerative diseases. The company leverages advanced scientific research to target these complex conditions, aiming to create effective treatment options.
Company News
Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Aardvark Therapeutics granted stock options to two new employees between July 8-14, 2025, with each option vesting over four years and tied to the company's inducement equity incentive plan.